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Abstract 
Objective: To compare the rate of cell proliferation and expression of antiapoptotic 
protein Bcl-2 between drug-induced gingival overgrowth (DIGO) and clinical healthy 
gingiva (CHG) and to establish associations with histopathological features. Material 
and Methods: Twenty specimens of DIGO and 20 CHG specimens were submitted to 
morphological and immunohistochemical analysis by light microscopy. Cell proliferation 
(Ki-67) and the expression of Bcl-2 were evaluated in epithelial cells and spindle-shaped 
mononuclear cells of the connective tissue by establishing the labeling index (LI). 
Results: In epithelial tissue, the mean LI for Ki-67 was 17.2% in DIGO and 21.71% in 
CHG (p = 0.137). The mean LIs for Bcl-2 in epithelial tissue were 14.67% and 10.24% in 
DIGO and CHG, respectively (p = 0.026). In connective tissue, DIGO and CHG 
specimens exhibited low LIs for Ki-67 and Bcl-2, with mean values of less than 0.5% in 
both groups. No significant differences in the LIs for Ki-67 or Bcl-2 in epithelial tissue 
were observed according to the degree of collagenization, degree of vascularization and 
intensity of inflammatory infiltration (p > 0.05). No significant correlations were 
observed between the LIs for Ki-67 and Bcl-2 (p > 0.05). Conclusion: The present 
results suggest that the pathogenesis of DIGO does not involve increased proliferation 
or decreased apoptosis of fibroblasts. On the other hand, the morphological pattern of 
elongated epithelial cristae observed in DIGO could mainly be due to the inhibition of 
keratinocyte apoptosis and not to increased proliferation of these cells. 
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Introduction 
Drug-induced gingival overgrowth (DIGO) is an important side effect of the administration 
of certain drugs, particularly anticonvulsants, immunosuppressants and calcium channel blockers 
(CCBs) [1]. Phenytoin, cyclosporin and nifedipine are usually associated with the development of 
DIGO, although they continue to be the drugs of choice for the prevention of epileptic seizures, 
prevention of transplant rejection and treatment of arterial hypertension, respectively [1-4]. 
The mechanisms whereby drugs with different pharmacological actions induce different 
types of gingival overgrowth (GO) with relatively similar clinical and histopathological 
characteristics remain a matter of debate [2,5,6]. Although the etiopathogenesis of DIGO is not fully 
understood, studies suggest this disorder to be induced by the rupture of homeostasis between the 
synthesis and degradation of collagen and other extracellular matrix (ECM) components, as well as 
between cell proliferation and apoptosis involving the gingival epithelium and connective tissue 
[1,2,6-10]. 
The pathogenesis of DIGO has been suggested to be related to the presence of a genetically 
determined subpopulation of drug-sensitive fibroblasts, which may respond by increasing cell 
proliferation/survival or by altering the synthesis and remodeling of ECM [3,6,11-13]. In an 
attempt to better understand the pathogenesis of DIGO, the present study evaluated cell 
proliferation rates (Ki-67) and the immunoexpression of antiapoptotic protein Bcl-2 in this tissue 
growth and compared the findings with those observed for clinically healthy gingiva (CHG). 
Additionally, the associations with histopathological features were established. 
 
Material and Methods 
Forty gingival specimens, including 20 cases of DIGO and 20 cases of CHG, obtained from 
the Oral Pathology Departments of the State University of Paraiba and Federal University of Rio 
Grande do Norte, were conveniently selected for this study. The size of the sample was defined by 
the number of available institutional archival cases. All gingival specimens were obtained from 
patients who had undergone oral surgery due to esthetic and functional reasons prior to periodontal 
therapy. The patients with DIGO had been receiving treatment with DIGO-inducing drugs for at 
least 6 months. In the CHG group, none of the subjects had taken medication known to affect 
periodontal status during the 3 months prior to enrollment. Serial sections were taken from tissue 
blocks and processed for morphological and immunohistochemical analysis.  
 
Histomorphological Study 
The selected specimens were cut into 5-µm thick histological sections, which were mounted 
on glass slides and stained with hematoxylin and eosin. The tissue sections were analyzed in a blind 
fashion by two previously trained examiners under a Leica DM500 light microscope (Leica 
Microsystems Vertrieb GmbH, Wetzlar, Germany). Histomorphological characteristics of epithelial 
and connective tissues were assessed. The degree of collagenization, degree of vascularization, and 
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intensity of inflammatory infiltration in the specimens were classified as discrete, moderate or 
intense. 
 
Immunohistochemistry 
For immunohistochemical study, 3-µm thick tissue sections were deparaffinized, immersed in 
3% hydrogen peroxide to block endogenous peroxidase activity, and washed in phosphate-buffered 
saline (PBS). Next, the sections were incubated in a moist chamber with the following primary 
antibodies: anti-Ki-67 (clone SP-6, Diagnostic Biosystems, Pleasanton, CA; antigen retrieval with 
citrate, pH 6.0, in a pressure cooker for 3 min; dilution 1:200; incubation 60 min) and anti-Bcl-2 
(clone 124, Dako, Carpinteria, CA; antigen retrieval with citrate, pH 6.0, in a pressure cooker for 3 
min; dilution 1:50; incubation overnight). The sections were then washed twice in PBS and treated 
with the labelled streptavidin biotin complex (LSAB + System-HRP, Dako) at room temperature to 
bind the primary antibodies. Peroxidase activity was visualized by immersing the tissue sections in 
diaminobenzidine (Liquid DAB+ Substrate, Dako), which resulted in a brown reaction product. 
Finally, the sections were counterstained with Mayer’s hematoxylin and coverslipped. Sections of 
normal human lymph nodes served as positive control for anti-Ki-67 and anti-Bcl-2 antibodies. As a 
negative control, the samples were treated as described above, except that the primary antibody was 
replaced with a solution of bovine serum albumin in PBS. 
 
Analysis of Immunostaining 
Immunohistochemical analysis was performed by two previously trained examiners in a blind 
fashion under a Leica DM500 light microscope (Leica Microsystems Vertrieb GmbH). The 
immunoexpression of Ki-67 and Bcl-2 was evaluated both in the epithelial tissue and in the 
connective tissue of the specimens by establishing the labeling index (LI). In connective tissue, the 
expression of Ki-67 and Bcl-2 was analyzed in oval/spindle-shaped mononuclear cells, which were 
morphologically compatible with fibroblasts. Using ×100 magnification, five fields containing the 
largest number of immunostained cells were identified. Images of each field were acquired with a 
Leica ICC50HD camera (Leica Microsystems Vertrieb GmbH) at ×400 magnification. A total of 
1,000 cells were counted in epithelial tissue and 500 cells in connective tissue using the ImageJ 
software (version 1.43u; National Institute of Mental Health, Bethesda, MD). The Ki-67 and Bcl-2 
LIs are expressed as the percentage of immunostained cells in relation to the total number of cells 
counted. 
 
Statistical Analysis 
The results obtained were submitted to statistical analysis using the Statistical Package for 
the Social Sciences (version 17.0; SPSS, Inc., Chicago, IL). The Kolmogorov-Smirnov test revealed a 
normal distribution of Ki-67 and Bcl-2 LIs in epithelial tissue. Therefore, the parametric Student t-
test was applied to compare mean Ki-67 and Bcl-2 LIs in epithelial tissue according to type of 
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specimen (DIGO versus CHG) and histomorphological characteristics. In connective tissue, 
statistical comparisons of the LIs for Ki-67 and Bcl-2 according to type of specimen (DIGO versus 
CHG) and histomorphological characteristics could not be performed due to the small number of 
immunopositive cases. Pearson’s correlation test was used to determine possible correlations 
between Ki-67 and Bcl-2 LIs in epithelial tissue. The level of significance was set at 5% (p < 0.05) for 
all tests. 
 
Ethical Aspects  
The study was approved by the Research Ethics Committee of State University of Paraíba 
(0076.0.133.000-12). 
 
Results 
Morphological Analysis 
Morphological analysis of the epithelial lining of CHG and DIGO specimens revealed areas 
of hyperplasia, acanthosis, hydropic degeneration, spongiosis and exocytosis that varied in extent 
and degree. Specifically in the case of DIGO, epithelial cristae exhibiting long extensions in the 
direction of the underlying connective tissue were identified in 11 (55.0%) of the 20 cases analyzed. 
In connective tissue, there was a higher frequency of cases exhibiting intense collagenization in 
DIGO (n = 18; 90.0%) compared to CHG (n = 12; 60.0%). Regarding vascularization, a higher 
proportion of CHG (n = 14; 70.0%) and DIGO (n = 11; 55.0%) specimens were classified as intense. 
Most DIGO cases (n = 13; 65.0%) exhibited an intense inflammatory infiltrate. On the other hand, a 
relatively similar distribution of the different degrees of inflammatory infiltration was observed in 
CHG (Table 1). 
 
Table 1. Distribution of cases of CHG and DIGO according to histomorphological characteristics. 
Characteristics 
Groups 
CHG 
n (%) 
DIGO 
n (%) 
Collagenization   
   Discrete 0 (0.0) 0 (0.0) 
   Moderate 8 (40.0) 2 (10.0) 
   Intense 12 (60.0) 18 (90.0) 
Vascularization   
   Discrete 0 (0.0) 0 (0.0) 
   Moderate 6 (30.0) 9 (45.0) 
   Intense 14 (70.0) 11 (55.0) 
Inflammatory infiltrate   
   Discrete 7 (35.0) 4 (20.0) 
   Moderate 6 (30.0) 3 (15.0) 
   Intense 7 (35.0) 13 (65.0) 
 
Immunohistochemical Analysis 
All cases of DIGO and CHG were positive for Ki-67 and Bcl-2 in epithelial tissue. 
Immunostaining for Ki-67 was observed in the nucleus of cells of the basal layer and, occasionally, in 
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the nucleus of parabasal cells (Fig. 1A and 1B). With respect to Bcl-2, immunostaining was detected 
in the cytoplasm of cells of the basal layer and sometimes in the cytoplasm of parabasal cells (Fig. 1C 
and 1D). 
Figure 1. Epithelial immunostaining for Ki-67 in the nucleus of cells of the basal and parabasal layers 
(arrows) in CHG (A) and in DIGO (B) (LSAB, ´100). Immunoexpression of Bcl-2 in the cytoplasm of 
epithelial cells of the basal layer (arrows) in CHG (C) and in DIGO (D) (LSAB, ´400). 
 
The mean LI for Ki-67 in epithelial tissue was 21.71% (range: 8.0% – 37.6%) in CHG and 
17.2% (range: 0.4% – 36.6%) in DIGO (p = 0.137). With respect to Bcl-2, the mean LI was 10.24% 
(range: 0.8% – 19.3%) in CHG and 14.67% (range: 2.4% – 27.1%) in DIGO, with the observation of a 
significant difference between groups (p = 0.026). No significant differences in the LIs for Ki-67 or 
Bcl-2 in epithelial tissue were observed according to the degree of collagenization, degree of 
vascularization and intensity of inflammatory infiltration (p > 0.05) (Table 2). 
 
Table 2. Number of cases, mean and range of LIs for Ki-67 and Bcl-2 in epithelial tissue and connective 
tissue, and their differences according to histomorphological characteristics. 
Characteristics n Epithelial tissue  Connective tissue Mean Range p  Mean Range 
Ki-67        
  Collagenization        
     Discrete/ Moderate 10 22.87 0.40 – 37.60 0.195  0.18 0.00 – 0.80 
     Intense 30 18.32 1.60 – 36.60   0.18 0.00 – 1.20 
  Vascularization        
     Discrete/ Moderate 15 16.65 1.60 – 31.90 0.152  0.14 0.00 – 1.20 
     Intense 25 21.14 0.40 – 37.60   0.20 0.00 – 1.00 
Pesq Bras Odontoped Clin Integr 2017, 17(1):e3331 
 
6 
  Inflammatory infiltrate        
     Discrete/ Moderate 20 18.59 7.20 – 37.60 0.572  0.04 0.00 – 0.40 
     Intense 20 20.32 0.40 – 36.60   0.33 0.00 – 1.20 
Bcl-2        
  Collagenization        
     Discrete/ Moderate 10 12.77 5.70 – 19.30 0.859  0.00 0.00 – 0.00 
     Intense 30 12.35 0.80 – 27.10   0.27 0.00 – 3.00 
  Vascularization        
     Discrete/ Moderate 15 12.92 2.90 – 20.70 0.721  0.24 0.00 – 0.80 
     Intense 25 12.17 0.80 – 27.10   0.18 0.00 – 3.00 
  Inflammatory infiltrate        
     Discrete/ moderate 20 13.25 2.90 – 20.40 0.434  0.15 0.00 – 0.80 
     Intense 20 11.65 0.80 – 27.10   0.26 0.00 – 3.00 
  
 In connective tissue, low Ki-67 and Bcl-2 immunostaining was observed in DIGO and CHG 
specimens (Fig. 2E and 2F). Only 7 (35.0%) of the CHG cases and 8 (40.0%) of the DIGO cases 
exhibited positive Ki-67 staining in oval/spindle-shaped mononuclear cells scattered in the ECM 
that were morphologically compatible with fibroblasts. For Bcl-2, 9 (45.0%) of the DIGO cases and 3 
(15.0%) of the CHG cases exhibited positive staining in oval/spindle-shaped mononuclear cells 
scattered in the ECM. 
 
Figure 2. Spindle-shaped mononuclear cell exhibiting nuclear positivity for Ki-67 (arrow) in CHG (E) 
and cytoplasmic positivity for Bcl-2 (arrow) in DIGO (F) (LSAB, ´400). 
 
Analysis of the LIs for Ki-67 in oval/spindle-shaped mononuclear cells of connective tissue 
revealed mean values of 0.15% (range: 0.0% – 1.0%) in CHG and 0.22% (range: 0.0% – 1.2%) in 
DIGO. The mean LIs for Bcl-2 were 0.06% (range: 0.0% – 0.6%) in CHG and 0.35% (range: 0.0% – 
3.0%) in DIGO. Table 2 shows the LIs for Ki-67 and Bcl-2 in connective tissue of the specimens 
according to the degree of collagenization, degree of vascularization and intensity of inflammatory 
infiltration.  
Pearson’s correlation test revealed no significant correlation between Ki-67 and Bcl-2 LIs in 
the epithelial tissue of the specimens (r = 0.067; p = 0.683). 
 
Discussion 
DIGO is an adverse effect of different drug categories, including anticonvulsants, CCBs and 
immunosuppressants [3,4,13,14]. Although the pharmacological effect of each drug is unique and 
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the exact pathogenesis of GO is not fully understood, the clinical and histopathological 
characteristics of DIGO are similar, irrespective of the drug [3,14]. 
Several factors have been proposed in an attempt to explain the susceptibility of gingival 
tissues to the effects of drugs, including exposure to higher drug concentrations in view of greater 
blood circulation and spaces between epithelial cells [9]. Furthermore, variations in individual 
susceptibility have been suggested, with different tissue responses being influenced by 
pharmacological and demographic variables, oral conditions and/or genetic predisposition [3,14]. 
DIGO has been suggested to be the result of a combination of factors, including disturbances 
of the balance between the synthesis and degradation of ECM molecules, particularly collagen, 
interference with the fibroblast proliferation rate, and accumulation of fibroblasts or keratinocytes 
due to the inhibition of apoptosis, prolonging the survival of these cells [2,4,7,10,11,13,15,16]. 
In the present immunohistochemical study, no significant differences in the LIs for Ki-67 in 
epithelial tissue were observed between DIGO and CHG, suggesting that the pattern of elongated 
epithelial cristae observed in the former is not related to increased proliferation of keratinocytes. In 
line with this suggestion, other studies also found no significant differences in epithelial cell 
proliferation rates between DIGO and normal oral mucosa specimens [11,17]. However, human 
studies and studies using animal models demonstrated an increase in the number of Ki-67-positive 
epithelial cells in GO induced by different drugs, such as cyclosporine and nifedipine, suggesting that 
these drugs can induce increased proliferation of these cells [2,7,8,18]. 
Also in epithelial tissue, a higher Bcl-2 LI was observed in DIGO compared to CHG (p = 
0.026), in agreement with previous findings [5,19]. Taken together with the results obtained for Ki-
67, the higher expression of Bcl-2 in DIGO observed here suggests that the pattern of epithelial 
cristae in these lesions, forming long extensions towards the connective tissue, is mainly related to 
the inhibition of keratinocyte apoptosis and not to increased proliferation of these cells. In line with 
this suggestion, studies using the terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick 
end labeling (TUNEL) technique, which is able to identify cells undergoing apoptosis, demonstrated 
lower rates of programmed cell death in the epithelial component of GO induced by nifedipine [11] 
and cyclosporine [9] when compared to CHG and inflamed gingiva. 
Analysis of Ki-67 and Bcl-2 LIs in connective tissue of DIGO revealed a much smaller 
number of immunopositive oval/spindle-shaped mononuclear cells. In agreement with these results, 
in a study investigating nifedipine-induced GO in an animal model, Bcl-2 expression was restricted 
to the gingival epithelium [6]. Furthermore, some authors studying a sample of cases of GO induced 
by CCBs, reported the absence of Ki-67 staining in fibroblasts of the lamina propria [20]. Similarly, 
in a study on cyclosporine-induced GO, it was observed that gingival fibroblasts were negative for 
proliferating cell nuclear antigen (PCNA) [10]. These findings suggest that the pathogenesis of GO 
does not involve increased proliferation or decreased apoptosis of fibroblasts. Despite this 
suggestion, a previous study reported strong positive staining for Ki-67 in fibroblasts of cases of 
nifedipine-induced GO [18]. Furthermore, it was observed the inhibition of cell cycle arrest in G1 in 
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human gingival fibroblasts cultured in medium containing phenytoin, probably as a result of an 
increase in phosphorylated CDK2 and Rb levels and a reduction in p21 and p27 protein levels [21]. 
The high percentage of cases of DIGO exhibiting intense collagenization (90%) observed in 
the present study agrees with the results of other studies suggesting that the development GO 
involves alterations in fibroblast metabolism represented by an increased secretory activity of ECM 
components and/or a reduction in the secretion of matrix metalloproteinases [2,14,22]. Within this 
context, there is evidence indicating that the cellular and molecular characteristics of DIGO might 
vary as a function of the drug used [23]. Studies have shown that cases of GO induced by phenytoin 
express high levels of transforming growth factor beta (TGF-b) and connective tissue growth factor 
(CCN2), which induce the synthesis and accumulation of ECM [23,24]. On the other hand, Kim et 
al. [25] observed that nifedipine-induced GO expresses high levels of periostin, a protein that 
increases the biosynthesis of ECM and stimulates fibrosis. According to these authors, nifedipine 
would stimulate signaling through TGF-b and consequently increase the expression of periostin 
[25]. 
Despite the above considerations, Brown and Arany [4] recently proposed a unified 
hypothesis to explain the pathogenesis of DIGO. According to these authors, CCBs, anticonvulsants 
and calcineurin inhibitors would first inhibit cation influx which results in reduced influx of folate 
into gingival fibroblasts. This event, in turn, would lead to modifications in the metabolism of matrix 
metalloproteinases and failure to activate collagenases. The reduced availability of activated 
collagenases would reduce the degradation of connective tissue and its consequent accumulation in 
gingival tissues [4]. 
Taken together, the data reported in the literature and the results obtained here suggest that 
the pathogenesis of DIGO is mainly related to alterations in fibroblast metabolism. The cellular and 
molecular mechanisms involved in this process remain incompletely understood. 
 
Conclusion 
The present results suggest that the pathogenesis of DIGO does not involve increased 
proliferation or reduced apoptosis of fibroblasts. On the other hand, the morphological pattern of 
elongated epithelial cristae observed in DIGO could mainly be due to the inhibition of keratinocyte 
apoptosis and not to the increased proliferation of these cells. 
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